New drugs against superbugs

对抗超级细菌的新药

• 批准号: nhmrc : GNT1059354
• 负责人: Prof Matthew Cooper
• 金额: $ 48.52万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/new-drugs-superbugs/1344689
• 关键词: New; drugs; against; superbugs

Infectious disease is a leading cause of death, and the emergence of 'superbugs' in the community and hospitals is of grave concern. We are developing new, powerful antibiotics that can kill superbugs using ‘forgotten’ drugs from the 1970s. These will combat bacteria that cause pneumonia, skin and urinary track infections; diseases that cause death and discomfort for thousands of Australians today. We will also develop methods to directly remove bacteria from blood infections.

传染病是导致死亡的主要原因，社区和医院出现的“超级细菌”令人严重关切。我们正在开发新的、强大的抗生素，可以使用20世纪70年代被遗忘的药物来杀死超级细菌。这些药物将与导致肺炎、皮肤和尿路感染的细菌作斗争，这些疾病今天会导致成千上万的澳大利亚人死亡和不适。我们还将开发直接从血液感染中清除细菌的方法。